Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiency
- 119 Downloads
GSK3β is prominent for its role in apoptosis signaling and has been shown to be involved in Parkinson’s disease (PD) pathogenesis. The overall effects of GSK3β activity on cell fate are well-established, but the effects of mitochondrial GSK3β activity on mitochondrial function and cell fate are unknown. Here we selectively expressed constitutively active GSK3β within the mitochondria and found that this enhanced the apoptosis signaling activated by the PD-mimetic NADH:ubiquinone oxidoreductase (complex I) inhibitors 1-methyl-4-phenylpyri-dinium ion (MPP+) and rotenone. Additionally, expression of GSK3β in the mitochondria itself caused a significant decrease in complex I activity and ATP production. Increased mitochondrial GSK3β activity also increased reactive oxygen species production and perturbed the mitochondrial morphology. Conversely, chemical inhibitors of GSK3β inhibited MPP+- and rotenone-induced apoptosis, and attenuated the mitochondrial GSK3β-mediated impairment in complex I. These results indicate that unregulated mitochondrial GSK3β activity can mimic some of the mitochondrial insufficiencies found in PD pathology.
KeywordsGlycogen synthase kinase-3β Parkinson’s disease 1-Methyl-4-phenylpyridinium Rotenone Mitochondria NADH:ubiquinone oxidoreductase Complex I Caspase-3 Reactive oxygen species Apoptosis
Unable to display preview. Download preview PDF.
- Hasegawa E, K Takeshige, T Oishi, Y Murai and S Minakami (1990) 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submi-tochondrial particles.Biochem. Biophys. Res. Commun. 170, 1049–1055.CrossRefPubMedGoogle Scholar
- Hoshi M, M Sato, S Kondo, A Takashima, K Noguchi, M Takahashi, K Ishiguro and K Imahori (2003) Different localization of tau protein kinase I/glycogen synthase kinase-3β from glycogen synthase kinase-3α in cerebellum mitochondria.J. Biochem. 118, 683–685.Google Scholar
- Javitch JA, RJ D’Amato, SM Strittmatter and SH Snyder (1985) Parkinsonism-inducing neurotoxin, N-methyl-4- phenyl-1,2,3,6 tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proc. Natl. Acad. Sci. USA 82, 2173–2177.CrossRefPubMedGoogle Scholar
- Ludolph AC, M Seelig, A Ludolph, P Novitt, CN Allen, PS Spencer and MI Sabri (1992) 3-Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants.Neurodegeneration 1, 155–161.Google Scholar
- Parker WD Jr, SJ Boyson and JK Parks (1989) Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann.Neurol. 26, 719–723.Google Scholar
- Swerdlow RH, JK Parks, SW Miller, JB Tuttle, PA Trimmer, JP Sheehan, JP Bennett Jr, RE Davis and WD Parker Jr (1996) Origin and functional consequences of the complex I defect in Parkinson’s disease. Ann.Neurol. 40, 663–671.Google Scholar